News

Potential Malaria vaccine gives hope in trial

Staff Writers | 24 Jan 2008 | Agence France Presse

A small trial of a malaria vaccine in Mali showed promising results, according to results published in the United States.

Malaria Vaccine Shows Promise in Small Trial

Staff Writers | 24 Jan 2008 | Washington Post

A new malaria vaccine looked strong in a small trial conducted in Mali by a team of international researchers. The vaccine -- designed to prevent the malaria parasite from entering blood cells -- was safe and provoked strong immune responses (up to a sixfold increase in vaccine-specific antibodies) in the 40 adults who received it, according to the 17-member research team, based at the Malaria Research and Training Center at the University of Bamako.

Seduced by 'winnable war' donors throw money at malaria

Staff Writers | 01 Jan 2008 | Mangalorean.Com

AFM's Jasson Urbach comments on possibility of malaria eradication in Madagascar
In Belalanda, a small village of reed huts in southwest Madagascar, women with faces smeared with a skin-lightening face pack file away from the local health clinic with packages on their heads. Each contains a free insecticide-treated anti-mosquito bed net, 1.5 million of which were distributed to pregnant women and children during the biannual Mother and Child Health Week in October.

Ghana: Mal 47 Malaria Vaccine Trial - So Far So Good

Maame Efua Moses | 14 Dec 2007 | Accra Daily Mail

Fifteen months after the first trial of the phase 2 (Mal 47) of the RTS'S malaria vaccine was administered to children in the Kintampo North and South Districts, ADM can confirm that most of these children are looking healthy and strong. Lawrence Gyabaa, Assistant Research Officer, KHRC who has done a study on the Mal 47 told ADM that the primary objective of his study was to investigate how community members perceived malaria prevention through the use of vaccines. He explained that the RTS,S malaria vaccine was created in 1987 and has been developed by GlaxoSmithKline (GSK) Biological in close collaboration with Walter Reed Army Institute of Research in the USA.


Ghana: Mal 47 Malaria Vaccine Trial - So Far So Good

Maame Efua Moses | 14 Dec 2007 | Accra Daily Mail

Fifteen months after the first trial of the phase 2 (Mal 47) of the RTS'S malaria vaccine was administered to children in the Kintampo North and South Districts, ADM can confirm that most of these children are looking healthy and strong.

A Potential Breakthrough in Malaria Prevention

Gilbert Ross | 17 Oct 2007 | American Council on Science and Health

Parents of infants in sub-Saharan Africa, where a million or more die each year, have new hope, thanks to a group of multinational researchers, led by Dr. John J. Aponte of the University of Barcelona and colleagues from Mozambique. They evaluated a new malaria vaccine's safety and efficacy in 214 infants in rural Mozambique, an area of high incidence of malaria, and found that the vaccine against Falciparum malaria, the most severe form, reduced the rate of new infections by almost two thirds.

Researchers launch global malaria tracking network

Staff Writers | 06 Sep 2007 | ABC News Australia

The World Antimalarial Research Network (WARN) is an online effort to spread research about malaria outbreaks that is often left languishing in health bureaucracies. Menzies School of Health Research spokesman Dr Ric Price says a three-year lag time between getting data and publishing research is too slow.

Ranbaxy to become first Indian pharma to launch NCE globally

Anil Joseph | 05 Sep 2007 | Hindustan Times

Ranbaxy has completed the second phase of the clinical trial of a revolutionary anti-malarial drug that could enable it to be the nation's first pharmaceutical company to launch a New Chemical Entity (NCE) globally.

FDA Clears Rapid Test for Malaria

Associated Press | 27 Jun 2007 | Houston Chronicle

The Food and Drug Administration recently approved a rapid diagnostic malaria test, the first of its kind approved in the United States.

Certain Combination Therapy Found More Effective For Treating Malaria In African Children

Wallace Rawen | 28 May 2007 | Medical News Today

Ugandan children who received the combination therapy of artemether-lumefantrine experienced a lower rate of treatment failure compared to other combination therapies